EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 23 (2016) Parasite, 23 (2016) 4 References
Open Access
Issue
Parasite
Volume 23, 2016
Article Number 4
Number of page(s) 9
DOI https://doi.org/10.1051/parasite/2016004
Published online 03 February 2016
  1. Bessieres MH, Swierczynski B, Cassaing S, Miedouge M, Olle P, Seguela JP, Pipy B. 1997. Role of IFN-gamma, TNF-alpha, IL4 and IL10 in the regulation of experimental Toxoplasma gondii infection. Journal of Eukaryotic Microbiology, 44(6), 87S. [CrossRef] [Google Scholar]
  2. Bradley PJ, Sibley LD. 2007. Rhoptries: an arsenal of secreted virulence factors. Current Opinion in Microbiology, 10(6), 582–587. [CrossRef] [PubMed] [Google Scholar]
  3. Buxton D, Maley SW, Wright SE, Rodger S, Bartley P, Innes EA. 2007. Toxoplasma gondii and ovine toxoplasmosis: new aspects of an old story. Veterinary Parasitology, 149(1–2), 25–28. [CrossRef] [PubMed] [Google Scholar]
  4. Chen J, Zhou DH, Li ZY, Petersen E, Huang SY, Song HQ, Zhu XQ. 2014. Toxoplasma gondii: protective immunity induced by rhoptry protein 9 (TgROP9) against acute toxoplasmosis. Experimental Parasitology, 139, 42–48. [CrossRef] [PubMed] [Google Scholar]
  5. Daryani A, Sharif M, Dadimoghaddam Y, Souteh MB, Ahmadpour E, Khalilian A, Sarvi S, Farazmand T, Kalani H, Rasouli M. 2014. Determination of parasitic load in different tissues of murine toxoplasmosis after immunization by excretory-secretory antigens using real time QPCR. Experimental Parasitology, 143, 55–59. [CrossRef] [PubMed] [Google Scholar]
  6. Dupont CD, Christian DA, Selleck EM, Pepper M, Leney-Greene M, Harms Pritchard G, Koshy AA, Wagage S, Reuter MA, Sibley LD, Betts MR, Hunter CA. 2014. Parasite fate and involvement of infected cells in the induction of CD4+ and CD8+ T cell responses to Toxoplasma gondii. PLoS Pathogens, 10(4), e1004047. [CrossRef] [PubMed] [Google Scholar]
  7. Dziadek B, Gatkowska J, Grzybowski M, Dziadek J, Dzitko K, Dlugonska H. 2012. Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice. Experimental Parasitology, 131(1), 133–138. [CrossRef] [PubMed] [Google Scholar]
  8. Echeverria PC, Matrajt M, Harb OS, Zappia MP, Costas MA, Roos DS, Dubremetz JF, Angel SO. 2005. Toxoplasma gondii Hsp90 is a potential drug target whose expression and subcellular localization are developmentally regulated. Journal of Molecular Biology, 350(4), 723–734. [CrossRef] [PubMed] [Google Scholar]
  9. El Hajj H, Demey E, Poncet J, Lebrun M, Wu B, Galeotti N, Fourmaux MN, Mercereau-Puijalon O, Vial H, Labesse G, Dubremetz JF. 2006. The ROP2 family of Toxoplasma gondii rhoptry proteins: proteomic and genomic characterization and molecular modeling. Proteomics, 6(21), 5773–5784. [CrossRef] [PubMed] [Google Scholar]
  10. Elmore SA, Jones JL, Conrad PA, Patton S, Lindsay DS, Dubey JP. 2010. Toxoplasma gondii: epidemiology, feline clinical aspects, and prevention. Trends in Parasitology, 26(4), 190–196. [CrossRef] [PubMed] [Google Scholar]
  11. Etheridge RD, Alaganan A, Tang K, Lou HJ, Turk BE, Sibley LD. 2014. The Toxoplasma pseudokinase ROP5 forms complexes with ROP18 and ROP17 kinases that synergize to control acute virulence in mice. Cell Host Microbe, 15(5), 537–550. [Google Scholar]
  12. Gazzinelli RT, Denkers EY, Sher A. 1993. Host resistance to Toxoplasma gondii: model for studying the selective induction of cell-mediated immunity by intracellular parasites. Infectious Agents and Disease, 2(3), 139–149. [PubMed] [Google Scholar]
  13. Hamidinejat H, Jalali MH, Jafari RA, Nourmohammadi K. 2014. Molecular determination and genotyping of Cryptosporidium spp. in fecal and respiratory samples of industrial poultry in Iran. Asian Pacific Journal of Tropical Medicine, 7(7), 517–520. [CrossRef] [PubMed] [Google Scholar]
  14. Huang B, Huang S, Chen Y, Zheng H, Shen J, Lun ZR, Wang Y, Kasper LH, Lu F. 2013. Mast cells modulate acute toxoplasmosis in murine models. PLoS One, 8(10), e77327. [CrossRef] [PubMed] [Google Scholar]
  15. Jensen KD, Hu K, Whitmarsh RJ, Hassan MA, Julien L, Lu D, Chen L, Hunter CA, Saeij JP. 2013. Toxoplasma gondii rhoptry 16 kinase promotes host resistance to oral infection and intestinal inflammation only in the context of the dense granule protein GRA15. Infection and Immunity, 81(6), 2156–2167. [CrossRef] [PubMed] [Google Scholar]
  16. Jordan KA, Hunter CA. 2010. Regulation of CD8+ T cell responses to infection with parasitic protozoa. Experimental Parasitology, 126(3), 318–325. [CrossRef] [PubMed] [Google Scholar]
  17. Li ZY, Chen J, Petersen E, Zhou DH, Huang SY, Song HQ, Zhu XQ. 2014. Synergy of mIL-21 and mIL-15 in enhancing DNA vaccine efficacy against acute and chronic Toxoplasma gondii infection in mice. Vaccine, 32(25), 3058–3065. [CrossRef] [PubMed] [Google Scholar]
  18. Liu Q, Wang F, Wang G, Zhao Q, Min J, Wang S, Cong H, Li Y, He S, Zhou H. 2014. Toxoplasma gondii: immune response and protective efficacy induced by ROP16/GRA7 multicomponent DNA vaccine with a genetic adjuvant B7-2. Human Vaccines & Immunotherapeutics, 10(1), 184–191. [CrossRef] [PubMed] [Google Scholar]
  19. Luft BJ, Remington JS. 1992. Toxoplasmic encephalitis in AIDS. Clinical Infectious Diseases, 15(2), 211–222. [CrossRef] [PubMed] [Google Scholar]
  20. Ma GY, Zhang JZ, Yin GR, Zhang JH, Meng XL, Zhao F. 2009. Toxoplasma gondii: proteomic analysis of antigenicity of soluble tachyzoite antigen. Experimental Parasitology, 122(1), 41–46. [CrossRef] [PubMed] [Google Scholar]
  21. Parthasarathy S, Fong MY, Ramaswamy K, Lau YL. 2013. Protective immune response in BALB/c mice induced by DNA vaccine of the ROP8 gene of Toxoplasma gondii. American Journal of Tropical Medicine and Hygiene, 88(5), 883–887. [CrossRef] [Google Scholar]
  22. Pulendran B. 2004. Modulating TH1/TH2 responses with microbes, dendritic cells, and pathogen recognition receptors. Immunologic Research, 29(1–3), 187–196. [CrossRef] [PubMed] [Google Scholar]
  23. Qiu W, Wernimont A, Tang K, Taylor S, Lunin V, Schapira M, Fentress S, Hui R, Sibley LD. 2009. Novel structural and regulatory features of rhoptry secretory kinases in Toxoplasma gondii. EMBO Journal, 28(7), 969–979. [CrossRef] [Google Scholar]
  24. Robert-Gangneux F, Dardé ML. 2012. Epidemiology of and diagnostic strategies for toxoplasmosis. Clinical Microbiology Reviews, 25(2), 264–296. [CrossRef] [PubMed] [Google Scholar]
  25. Rodrigues MM, Boscardin SB, Vasconcelos JR, Hiyane MI, Salay G, Soares IS. 2003. Importance of CD8 T cell-mediated immune response during intracellular parasitic infections and its implications for the development of effective vaccines. Anais da Academia Brasileira de Ciencias, 75(4), 443–468. [CrossRef] [PubMed] [Google Scholar]
  26. Sayles PC, Gibson GW, Johnson LL. 2000. B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii. Infection and Immunity, 68(3), 1026–1033. [CrossRef] [PubMed] [Google Scholar]
  27. Sharma P, Chitnis CE. 2013. Key molecular events during host cell invasion by Apicomplexan pathogens. Current Opinion in Microbiology, 16(4), 432–437. [CrossRef] [PubMed] [Google Scholar]
  28. Sibley LD, Adams LB, Krahenbuhl JL. 1993. Macrophage interactions in toxoplasmosis. Immunologic Research, 144(1), 38–40. [CrossRef] [Google Scholar]
  29. Solano Aguilar GI, Beshah E, Vengroski KG, Zarlenga D, Jauregui L, Cosio M, Douglass LW, Dubey JP, Lunney JK. 2001. Cytokine and lymphocyte profiles in miniature swine after oral infection with Toxoplasma gondii oocysts. International Journal for Parasitology, 31(2), 187–195. [CrossRef] [PubMed] [Google Scholar]
  30. Touzot M, Cacoub P, Bodaghi B, Soumelis V, Saadoun D. 2014. IFN-alpha induces IL-10 production and tilt the balance between Th1 and Th17 in Behçet disease. Autoimmunity Reviews, 14(5), 370–375. [CrossRef] [PubMed] [Google Scholar]
  31. Velge-Roussel F, Marcelo P, Lepage AC, Buzoni-Gatel D, Bout DT. 2000. Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments. Infection and Immunity, 68(2), 969–972. [CrossRef] [PubMed] [Google Scholar]
  32. Villavedra M, Rampoldi C, Carol H, Baz A, Battistoni JJ, Nieto A. 2001. Identification of circulating antigens, including an immunoglobulin binding protein, from Toxoplasma gondii tissue cyst and tachyzoites in murine toxoplasmosis. International Journal for Parasitology, 31(1), 21–28. [CrossRef] [PubMed] [Google Scholar]
  33. Wang HL, Li YQ, Yin LT, Meng XL, Guo M, Zhang JH, Liu HL, Liu JJ, Yin GR. 2013. Toxoplasma gondii protein disulfide isomerase (TgPDI) is a novel vaccine candidate against toxoplasmosis. PLoS One, 8(8), e70884. [CrossRef] [PubMed] [Google Scholar]
  34. Wang HL, Yin LT, Zhang TE, Guan L, Meng XL, Liu HL, Yin GR. 2014. Construction, expression and kinase function analysis of an eukaryocyte vector of rhoptry protein 17 in Toxoplasma gondii. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, 32(1), 29–33. [PubMed] [Google Scholar]
  35. Wang HL, Zhang TE, Yin LT, Pang M, Guan L, Liu HL, Zhang JH, Meng XL, Bai JZ, Zheng GP, Yin GR. 2014. Partial protective effect of intranasal immunization with recombinant Toxoplasma gondii rhoptry protein 17 against toxoplasmosis in mice. PLoS One, 9(9), e108377. [Google Scholar]
  36. Wang PY, Yuan ZG, Petersen E, Li J, Zhang XX, Li XZ, Li HX, Lv ZC, Cheng T, Ren D, Yang GL, Lin RQ, Zhu XQ. 2012. Protective efficacy of a Toxoplasma gondii rhoptry protein 13 plasmid DNA vaccine in mice. Clinical and Vaccine Immunology, 19(12), 1916–1920. [CrossRef] [Google Scholar]
  37. Wang S, Hassan IA, Liu X, Xu L, Yan R, Song X, Li X. 2015. Immunological changes induced by Toxoplasma gondii Glutathione-S-Transferase (TgGST) delivered as a DNA vaccine. Research in Veterinary Science, 99, 157–164. [CrossRef] [PubMed] [Google Scholar]
  38. Weiss LM, Dubey JP. 2009. Toxoplasmosis: a history of clinical observations. International Journal for Parasitology, 39(8), 895–901. [CrossRef] [PubMed] [Google Scholar]
  39. Xu Y, Zhang NZ, Tan QD, Chen J, Lu J, Xu QM, Zhu XQ. 2014. Evaluation of immuno-efficacy of a novel DNA vaccine encoding Toxoplasma gondii rhoptry protein 38 (TgROP38) against chronic toxoplasmosis in a murine model. BMC Infectious Diseases, 14, 525. [CrossRef] [PubMed] [Google Scholar]
  40. Yamamoto M, Takeda K. 2012. Inhibition of ATF6beta-dependent host adaptive immune response by a Toxoplasma virulence factor ROP18. Virulence, 3(1), 77–80. [CrossRef] [PubMed] [Google Scholar]
  41. Yin GR, Meng XL, Ma GY, Ma XM. 2007. Intranasal immunization with mucosal complex vaccine protects mice against Toxoplasma gondii. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, 25(4), 290–294. [PubMed] [Google Scholar]
  42. Yuan ZG, Zhang XX, He XH, Petersen E, Zhou DH, He Y, Lin RQ, Li XZ, Chen XL, Shi XR, Zhong XL, Zhang B, Zhu XQ. 2011. Protective immunity induced by Toxoplasma gondii rhoptry protein 16 against toxoplasmosis in mice. Clinical and Vaccine Immunology, 18(1), 119–124. [CrossRef] [Google Scholar]
  43. Yuan ZG, Zhang XX, Lin RQ, Petersen E, He S, Yu M, He XH, Zhou DH, He Y, Li HX, Liao M, Zhu XQ. 2011. Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18. Vaccine, 29(38), 6614–6619. [CrossRef] [PubMed] [Google Scholar]
  44. Zhang NZ, Chen J, Wang M, Petersen E, Zhu XQ. 2013. Vaccines against Toxoplasma gondii: new developments and perspectives. Expert Review of Vaccines, 12(11), 1287–1299. [CrossRef] [PubMed] [Google Scholar]
  45. Zhang NZ, Xu Y, Huang SY, Zhou DH, Wang RA, Zhu XQ. 2014. Sequence variation in Toxoplasma gondii rop17 gene among strains from different hosts and geographical locations. Scientific World Journal, 2014, 349325. [Google Scholar]
  46. Zheng B, Lu S, Tong Q, Kong Q, Lou D. 2013. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma gondii is a novel vaccine candidate against toxoplasmosis in mice. Vaccine, 31(41), 4578–4584. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.